About us
Scintomics Molecular, Applied Theranostics Technologies (SCI-att) is a growing player in the radiopharmaceutical business with a particular strategic emphasis on providing unrestricted supply and support of proprietary and innovative tracer technology and non-IP protected precursors.
The well-known GRP Module Series became part of SCI-att in April 2020 when SCI-att took over the Module business from its parent company Scintomics, which has been selling and installing fully automated production systems for established radio-pharmaceuticals in clinical facilities around the world since 2006.
 |
2Quart Medical Mezenhof 83 1742 Schagen NOORD-HOLLAND / Netherlands |
 |
CardiRad Sweden AB Karusellplan 8 12631 Hägersten Sweden |
 |
DSD Pharma GmbH Schuhmeierstraße 24 1140 Purkersdorf Austria |
 |
Global Medical Solutions Pty Ltd 253 Princes Hwy 2205 Arncliffe, NSW Australia |
 |
Health Technologies Sp. Z.o.o. Chocimska 20/101 00-791 Warszawa Poland |
 |
Imaxeon Pty. Ltd. Unit 1, 38-46 South Street Rydalmere NSW 2116 Australia |
 |
Mediray GPC Aetideon 2 & Mesogeion 224 15561 Holargos Athen Greece |
 |
Nepha Tibbi Cihazlar SAN.VE TIC. A.S Sedat Simavi Sok, Gul Apt 21A 06550 Çankaya/Ankara, Turkey |
 |
QT Instruments (S) Pte. Ltd. 192 Pandan Loop SGP #06-20 Pantech Business Hub 128381 Singapore |
 |
TECNASA, Tecnologias Asociadas c/ Primera, 27 28016 Madrid Spain |
 |
VEGA Medical Boul. Bulgaria 109, fl.2, office 2.6 Vertigo Tower 1404 Sofia Bulgaria |
Our Scintomics/att History
2006
Founded by Prof. H. J. Wester (TUM)
Hotbox series & Gallelut (still running at several customer sites)
2010
Start of:
Innovative tracer techniques and Radiopharmaceuticals for Imaging and Therapy, (IP protected in several countries)
2018
Scintomics Molecular, att GmbH founded by Scintomics GmbH
New portfolio with cassettes, consumables and precursors, such as PSMA I&T (patent protected in several EU countries and Australia) and next generation PSMA inhibitors for radioligand therapy.
2020
att takes over Module Business from Scintomics
new siGRP-Module:
for production of the two SiFA-based radiopharmaceuticals [F-18]siPSMA and [F-18]SiFAlin-TATE – ready to compete with Ga-68 !
Our Gallery
